Omnicell Inc's Corporate Customers have recorded an advance in their cost of revenue by 2.33 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -2.85 %. During the corresponding time, Omnicell Inc recorded a revenue increase by 15.03 % year on year, sequentially revenue fell by -1.89 %. While revenue at the Omnicell Inc's corporate clients recorded rose by 3.34 % year on year, sequentially revenue fell by -1.25 %.
Omnicell Inc's Customers have recorded an advance in their cost of revenue by 2.33 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -2.85 %, for the same period Omnicell Inc recorded revenue increase by 15.03 % year on year, sequentially revenue fell by -1.89 %.
Omnicell Inc's Comment on Sales, Marketing and Customers
The company provides solutions for the healthcare sector, focusing on pharmacists and nurses across various care settings. Their offerings target hospital and health system markets, enabling end-to-end medication management through Central Pharmacy automation, robotics, IV sterile compounding, and Point of Care automated dispensing in Nursing Units and Operating Room/Procedural areas. They also support Consolidated Pharmacy Service Center operations. Additionally, the company serves Points of Care markets, including hospitals and ambulatory care settings, where their dispensing systems are increasingly used. Their solutions address challenges such as budget constraints, workforce shortages, and drug diversion liability by enhancing automation, visibility, and medication management outcomes in line with the Autonomous Pharmacy vision.
Omnicell Inc’s Comment on Sales, Marketing and Customers
The company provides solutions for the healthcare sector, focusing on pharmacists and nurses across various care settings. Their offerings target hospital and health system markets, enabling end-to-end medication management through Central Pharmacy automation, robotics, IV sterile compounding, and Point of Care automated dispensing in Nursing Units and Operating Room/Procedural areas. They also support Consolidated Pharmacy Service Center operations. Additionally, the company serves Points of Care markets, including hospitals and ambulatory care settings, where their dispensing systems are increasingly used. Their solutions address challenges such as budget constraints, workforce shortages, and drug diversion liability by enhancing automation, visibility, and medication management outcomes in line with the Autonomous Pharmacy vision.
Sources:
Omnicell inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Omnicell inc’s corporate clients.
For your research, we’ve provided 9 tables on Omnicell inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
100.17 %
3.37 %